*Prices reflect U.S. average retail price

Aldesleukin is a form of recombinant interleukin-2. It is manufactured using recombinant DNA technology and is marketed as a protein therapeutic and branded as Proleukin. It has been approved by the Food and Drug Administration (FDA) and in several European countries for the treatment of cancers (malignant melanoma, renal cell cancer) in large intermittent doses and has been extensively used in continuous doses...Wikipedia

Manufacturer's Website: Proleukin                                                                                                                            Average retail cost: $6,049/injection